SCHEMBL7947844

SCHEMBL7947844

CCC(=Cc1ccccc1C)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
TSHR P16473 1/20 0.44
TBXAS1 P24557 2/20 0.40
LMNA P02545 4/20 0.40
KDM4E B2RXH2 2/20 0.40
GMNN O75496 1/20 0.40
PMP22 Q01453 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
ERCC5 P28715 1/20 0.39
FEN1 P39748 1/20 0.39
EPHX2 P34913 2/20 0.38
PPARG P37231 1/20 0.38
PTGES O14684 1/20 0.38
ALOX5 P09917 1/20 0.38
CTBP2 P56545 1/20 0.37
PKM P14618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24587500 1.00 ALDH1A1 (0.44) ALDH1A1TSHRTBXAS1LMNAKDM4E
SCHEMBL9049685 0.84 TSHR (0.50) ALDH1A1TSHRLMNAKDM4EGMNN
SCHEMBL9049678 0.84 TSHR (0.50) ALDH1A1TSHRLMNAKDM4EGMNN
SCHEMBL11829415 0.82 NFKB1 (0.46) ALDH1A1TBXAS1LMNAKDM4ESMN1; SMN2
SCHEMBL12498707 0.81 HSD11B1 (0.44) TBXAS1LMNAKDM4ECYP3A4CYP2C9
SCHEMBL5179024 0.81 TBXAS1 (0.40) TBXAS1LMNAKDM4ECYP3A4CYP2C9
SCHEMBL3377294 0.81 CYP1A2 (0.50) ALDH1A1TBXAS1LMNASMN1; SMN2CYP3A4
SCHEMBL12498711 0.81 HSD11B1 (0.44) TBXAS1LMNAKDM4ECYP3A4CYP2C9
SCHEMBL16795914 0.81 TRPA1 (0.47) ALDH1A1TBXAS1LMNASMN1; SMN2KMT2A
SCHEMBL9390821 0.81 TRPA1 (0.47) ALDH1A1TBXAS1LMNASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211197-B1 CARBOXYLIC ACID OR TETRAZOLE DERIVATES; ANALGESICS, ANTIPYRETICS, AND ANTIINFLAMMATORY AGENTS; SIDE EFFECT REDUCTION MERCK FROSST CANADA & CO. (CA) 2001-04-03 US disclosed